Primary Care Diabetes
Volume 3, Issue 3 , Pages 189-191, August 2009

GADA testing: The current state of knowledge

  • H. Davies

      Affiliations

    • Centre for Health Information, Research and Evaluation [CHIRAL], The School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, United Kingdom
    • Corresponding Author InformationCorresponding author. Tel.: +44 01792 513685; fax: +44 01792 513400.
  • ,
  • S. Brophy

      Affiliations

    • Centre for Health Information, Research and Evaluation [CHIRAL], The School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, United Kingdom
  • ,
  • S.C. Bain

      Affiliations

    • Diabetes Research Group, Institute for Life Sciences, Swansea University, Singleton Park, Swansea SA2 8PP, United Kingdom
  • ,
  • J.W. Stephens

      Affiliations

    • Diabetes Research Group, Institute for Life Sciences, Swansea University, Singleton Park, Swansea SA2 8PP, United Kingdom
  • ,
  • J. Lewis

      Affiliations

    • Immunology Department, Singleton Hospital, Abertawe Bro-Morgannwg NHS University Trust, Sketty Lane, Swansea SA2 8QA, United Kingdom
  • ,
  • S. Luzio

      Affiliations

    • Diabetes Research Unit, Academic Centre, Llandough Hospital, Penarth CF64 2XX, United Kingdom
  • ,
  • G. Dunseath

      Affiliations

    • Diabetes Research Unit, Academic Centre, Llandough Hospital, Penarth CF64 2XX, United Kingdom
  • ,
  • C. Beaverstock

      Affiliations

    • Diabetes Unit, Neath Port Talbot Hospital, Abertawe Bro-Morgannwg NHS University Trust, Baglan Way, Port Talbot SA12 7BX, United Kingdom
  • ,
  • D.R.R. Williams

      Affiliations

    • Centre for Health Information, Research and Evaluation [CHIRAL], The School of Medicine, Swansea University, Singleton Park, Swansea SA2 8PP, United Kingdom

Received 12 June 2009; received in revised form 21 July 2009; accepted 22 July 2009. published online 01 September 2009.

Abstract 

This review considers the current knowledge and practice of GADA testing people with diabetes in Europe and the UK. Important issues are raised, including interpretation of the results and the clinical relevance of the GADA titre. Recommendations are made towards standardising GADA testing, using World Health Organization units.

Keywords: Glutamic acid decarboxylase autoantibodies, Latent autoimmune diabetes in adults

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S1751-9918(09)00079-5

doi:10.1016/j.pcd.2009.07.002

Primary Care Diabetes
Volume 3, Issue 3 , Pages 189-191, August 2009